Skip to content
Atlas Research Compounds

Selank vs. Pinealon

A structured research comparison between Selank and Pinealon across compound identity, research category, evidence maturity, and interpretation boundaries.

Tuftsin-related neuropeptide

Selank

Investigated in neurochemical, stress-response, and immune-neural signaling models.

Evidence score2/5

Early human evidence

The score summarizes evidence maturity, not safety, effectiveness, or suitability for any use.

Open full profile →

Short peptide bioregulator

Pinealon

Proposed as a short peptide bioregulator; direct molecular targets and independent replication remain limited.

Evidence score1/5

Preclinical foundation

The score summarizes evidence maturity, not safety, effectiveness, or suitability for any use.

Open full profile →

Side-by-side research context

DimensionSelankPinealon
Catalog identitySelank is mapped to tuftsin-related neuropeptide research.Pinealon is mapped to short peptide bioregulator research.
Research categorySelank is primarily organized around stress-response and cognition research.Pinealon is primarily organized around aging, cognition, and bioregulator models.
Interpretive boundaryUse the Selank profile and verified study pages before inferring mechanism or outcomes.Use the Pinealon profile and verified study pages before inferring mechanism or outcomes.

Combined literature starting points

Comparison pages organize differences; they do not establish superiority, equivalence, or individual suitability.

  1. 01

    Selank literature index

    PubMed, U.S. National Library of Medicine · Database

    Open source
  2. 02

    Atlas internal research database

    Internal Research Database · 2026 · Database

    Open source
  3. 03

    Short peptide bioregulator literature index

    PubMed, U.S. National Library of Medicine · Database

    Open source